← Open Payments lookup

PAMELA LOTT: Open Payments

NPI 1578640959 · COLUMBUS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,108 in 115 payments from 15 companies in 2025. Trend: 2023 $1,300 · 2024 $2,017 · 2025 $2,108

Food & beverage: $2,009Education: $99
CompanyPaymentsAmount
Janssen Biotech, Inc.18$393
ABBVIE INC.25$295
Madrigal Pharmaceuticals16$294
GENZYME CORPORATION11$245
Aimmune Therapeutics, Inc.12$200
Takeda Pharmaceuticals U.S.A., Inc.10$192
QOL Medical, LLC6$146
Ardelyx, Inc.4$102
Lilly USA, LLC4$62
Regeneron Healthcare Solutions, Inc.2$50

Products named: TREMFYA, DUPIXENT, REZDIFFRA, ZENPEP, ENTYVIO, RINVOQ, Sucraid, IBSRELA.

Industry payments across MS — which companies pay providers there.